Patent portfolios and Patent Assertion Entities: antitrust issues and future perspective under the Unified Patent Court
DOI
https://doi.org/10.25267/%20REJUCRIM.2024.i9.10Información
Resumen
Protecting research has always been a relevant issue in order to foster innovation, especially in the pharmaceutical field. Intellectual property rights protection plays a main role in the current economy since it allows companies to monetize efforts and investments in research and development through the patent system. However, in the past years antitrust authorities found themselves in front of a tangled question: the strategic use of patents in order to unlawfully prolong the protection time and, by so doing, to exclude competitors from the market. The strategic use of patent portfolios and the rapid growth of Patent Assertion Entities represent a significant antitrust issue which needs to be investigated, especially following the Agreement on unitary patent and Unified Patent Court and the related deep changes in the European patent system in order to verify if such Agreement can be a useful tool against strategic and anti-competitive conducts.
Palabras clave
Descargas
Cómo citar
Licencia
Derechos de autor 2024 Pietro Cappabianca
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Citas
AREZZO, E., Brevetti essenziali, dominanza e abuso nel settore delle information & communication technologies, Giurisprudenza commerciale, 5, 2019.
ARMSTRONG, A., MUELLER, J.J., SYRETT, T.D., The Smartphone Royalty Stack: Surveying Royalty Demands for the Components Within Modern Smartphones, 2014, 69 (in https://ssrn.com/abstract=2443848, consulta 15.1.2024).
BRINSON, J. D., Patent misuse: time for a change, in Rutgers Computer & Technology Law Journal, 16, 2, 1990.
BURCHFIEL, K. J., Patent misuse and antitrust reform: “Blessed be the tie?”, Harvard Journal of Law & Technology, 4, 1991.
BURRONE, E., GOTHAM, D., GREY, A., DE JOONCHEERE, K., MAGRINI, N., MARTEI, Y. M., GORE, C., KIENY, M. P., Patent pooling to increase access to essential medicines, in Bulletin of World Health Organization, 97, 2019.
CASCIONE, C. M., Art. 833 c.c., in Codice civile commentato (a cura di G. Bonillini, M. Confortini, C. Granelli), p. 3, (www.onelegale.it, consulta: 29.1.2024).
COLANGELO M., Concorrenza e proprietà intellettuale nel settore farmaceutico in Europa dopo AstraZeneca, Giurisprudenza commerciale, 4, 2013.
COLANGELO, G., Gli accordi di patent pooling: un’analisi comparata della regolamen-tazione antitrust, Il diritto industriale, 1, 2009.
COLANGELO, G., Il caso IMS, Mercato Concorrenza Regole, 2, 2004.
COLANGELO, G., Il mercato dell’innovazione. Brevetti, Standard e Antitrust, Milano, Quaderni di Giurisprudenza Commerciale, Giuffrè, Milano, 2016.
COLANGELO, G., Mercato e cooperazione tecnologica. I contratti di patent pooling, Quaderni di AIDA, Milano, 2008.
COTROPIA, C. A., KESAN, J. P., SCHWARTS, D. L., Unpacking Patent Assertion Entities, in Minnesota Law Review, 2, 99, 2014.
DEWATRIPONT,M., LEGROS, P., ‘Essential’ patents, FRAND royalties and technolo-gical standards, The Journal of Industrial Economy, 4, 2013.
FABBIO, P., La proporzionalità dell’inibitoria per violazione dei diritti di proprietà inte-llettuale, Diritto industriale, 2, 2021.
GALETOVIC, A., GUPTA, K., Royalty stacking and Standard Essential Patents: theory and evidence from the World Mobile Wireless Industry, 2 (https://wwws.law.northwestern.edu/research-faculty/clbe/events/innovation/documents/galeto-vic_royalty_stacking_060416_gg.pdf, consulta: 15.1.2024).
GALLI, C., Il tribunale europeo dei brevetti e il brevetto unitario tra opportunità, nuove sfide e occasioni mancate, Il diritto industriale, 3, 2023.
GERADIN, D., Patent Assertion Entities and EU competition law, in Journal of Competition Law & Economics, 15, 2-3, 2020.
GERADIN, D., Standardization and technological innovation: some reflection on ex-ante licensing, FRAND and the proper means to reward innovators, Tilec Discussion Papers, 17, 2006.
GHIDINI, G., CAVANI, G., PISERÀ, P. F., Il caso Pfizer, in Rivista di diritto civile, 6, 2015.
GHIDINI, G., TRABUCCO, G., Il calcolo dei diritti di licenza in regime FRAND: tre criteri pro-concorrenziali di ragionevolezza, in Rivista di orizzonti del diritto com-merciale, 1, 2017.GIAMPAOLINO, C. F., Misuse degli IP rights, AIDA, 2013.
LAYNE-FARRAR, A., LLOBET, G., To Join Or Not To Join: Examining Patent Pool Participation and Rent Sharing Rules, International Journal of Industrial Organization, 29, 2011.
LIBERTINI, M., Abuso del diritto e abuso di posizione dominante, Rivista di orizzonti del diritto commerciale, 3, 2018.
LIM, D., Patent misuse and antitrust: rebirth or false dawn?, in Michigan Telecommunication And Technology Law Review, 20, 2, 2014.LOVE, B. J.,Patent assertion entities in Europe, in Patent assertion entities and competi-tion policy, Cambridge, 2017, p. 104.
LUMAN III, J. F., DODSON, C. L., No longer a myth, the emergence of the patent troll: stifling innovation, increasing litigation and extorting billions, Intellectual Property & Technology Law Journal, 18, 5, 2006.
MAFFEI, T. F. The patent misuse doctrine: a balance of patent rights and the public inter-est, Boston College Law Review, 11, 1, 1969.
MARZANO, P., Diritto d’autore ed antitrust tra mercati concorrenziali e network eco-nomies, Rivista del diritto d’autore, 1998.
MERGES, R. P., Contracting into Liability Rules: Intellectual Property Rights and Collective Rights Organizations, California Law Review, 84, 1996.MORO VISCONTI, R., Le Royalty Companies, Il diritto industriale, 5, 2011.
MUSELLI, A., Brevetti essenziali e antitrust: false FRAND or true enemy? Commento alle decisioni Motorolae Samsung, in Concorrenza e Mercato, 1, 2015.
NELSON, P. B., Patent pools: An Economic assessment of Current Law and Policy, Rutgers Law Journal, 38, 2007.
NIKOLIC, I., Are patent assertion entities a threat to Europe?, Journal of Intellectual Property Law & Practice, 19, 6, 2019.OSTI, C., Il caso Huawei: ancora sul diritto della concorrenza come clausola generale del diritto civile, in Rivista di Orizzonti del Diritto Commerciale, 1, 2017.
PARCHOMOVSKY, G., WAGNER, R. P., Patent portfolios, in University of Pennsylvania Law Review, 154, 1, 2005.PIRAINO F., Il divieto di abuso del diritto, in Europa e diritto privato, 1, 2013.
POPOFSKY, M. S., Patent Assertion Entities and Antitrust: Operating Company Patent Transfers, 2013, 4 (www.antitrustsource.com, last seen 29/1/2024).
RISCH, M., Patent portfolios as securities, in 63 Duke Law Journal, 89, 2013.
RISCH, M., Patent troll myths, Sethon Hall Law Review, 42, 2010.
SANCHEZ GARCÌA, L., El fenómeno cross-licensing en el derecho español de patentes, Revista de Direito Brasileira, 8, 2018.
SCOTT MORTON, F. C., SHAPIRO, C., Strategic patent acquisitions, Antitrust Law Journal, 2, 2014.
SCUFFI, M., Brevetti essenziali, abuso e condizioni FRAND, Il societario-focus 24th of January 2018.Sokol D., Patent Assertion Entities in Europe, 2015 (https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2689350 consulta: 15/12/2023).
SPULBER, D. F., Standard Setting Organization and Standard Essential Patents: voting and markets, The Economic Journal, 129, 2018.
THUMM, N., The good, the bad and the ugly – the future of patent assertion entities in Europe, Technology Analysis & Strategic Management, 30, 9, 2018.
TURNER, J. D. C., Intellectual property and EU competition law, Oxford University Press, Oxford, 2015.
VENEGAS, V. B., Intellectual property rights, enforcement costs and EU competition law, in Journal of Antitrust Enforcement, 11, 2023.
WRIGHT, J. D., GINSBURG, D. H., Patent assertion entities and antitrust: a competi-tion cure for a litigation disease?, Antitrust Law Journal, 79, 2, 2014.ZAGATO L., TRIPs e diritti umani, AIDA, 1, 2014.